Trial Profile
A Six-Month Open Label, Multicenter, Randomized Study to Evaluate the Incidence of New Onset Diabetes Mellitus and Glucose Metabolism in Patients Receiving Cyclosporine Microemulsion With C-2 Monitoring Versus Tacrolimus After de Novo Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2013
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Mycophenolate mofetil; Mycophenolate sodium; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms DIRECT; DIRECT
- Sponsors Novartis
- 28 Jan 2011 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 30 Aug 2009 Results of multivariate analysis presented at the 14th Congress of the European Society for Organ Transplantation.
- 18 Sep 2006 Status change